Last reviewed · How we verify
METRONIDAZOLE BENZOATE
At a glance
| Generic name | METRONIDAZOLE BENZOATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Nitazoxanide in Patients With Ulcerative Colitis (PHASE2)
- Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine (PHASE1)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
- Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules (PHASE1)
- Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate (PHASE1)
- Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. (PHASE1)
- Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- METRONIDAZOLE BENZOATE CI brief — competitive landscape report
- METRONIDAZOLE BENZOATE updates RSS · CI watch RSS